LncRNA Snhg3 Aggravates Hepatic Steatosis via PPARγ Signaling
Authors:
Preprint
- 16 September 2024
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Abstract
LncRNAs are involved in modulating the individual risk and the severity of progression in metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate the role of lncRNA Snhg3 in the development and progression of MASLD, along with the underlying mechanisms. In vitro and in vivo experiments revealed that Snhg3 is involved in lipid metabolism and steatosis. The result showed that Snhg3 was significantly downregulated in the liver of high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted the expression of Snhg3 and overexpression of Snhg3 increased lipid accumulation in primary hepatocytes. Furthermore, hepatocyte-specific Snhg3 deficiency decreased body and liver weight, alleviated hepatic steatosis and promoted hepatic fatty acid metabolism in DIO mice, whereas overexpression induced the opposite effect. Mechanistically, Snhg3 promoted the expression, stability and nuclear localization of SND1 protein via interacting with SND1, thereby inducing K63-linked ubiquitination modification of SND1. Moreover, Snhg3 decreased the H3K27me3 level and induced SND1-mediated chromatin loose remodeling, thus reducing H3K27me3 enrichment at the Pparγ promoter and enhancing Pparγ expression. The administration of PPARγ inhibitor T0070907 improved Snhg3-aggravated hepatic steatosis. Our study revealed a new signaling pathway, Snhg3/SND1/H3K27me3/PPARγ, responsible for MASLD and indicates that lncRNA-mediated epigenetic modification has a crucial role in the pathology of MASLD.Keywords
All Related Versions
This publication has 66 references indexed in Scilit:
- CIDE proteins and their regulatory mechanisms in lipid droplet fusion and growthFEBS Letters, 2024
- SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9Cell, 2023
- Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese miceCellular and Molecular Life Sciences, 2023
- Mechanisms and disease consequences of nonalcoholic fatty liver diseaseCell, 2021
- Are spliced ncRNA host genes distinct classes of lncRNAs?Theory in Biosciences, 2020
- Molecular and cellular insights into the role of SND1 in lipid metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2020
- snoRNA U17 Regulates Cellular Cholesterol TraffickingCell Metabolism, 2015
- Epigenetics in liver diseaseHepatology, 2014
- lincRNAs: Genomics, Evolution, and MechanismsCell, 2013
- Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27Cell Metabolism, 2008